Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
Rhea-AI Summary
Lumexa Imaging (NASDAQ: LMRI) will release first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The company will host a conference call and live webcast at 5:00 p.m. ET. The live audio webcast will be available at the investor relations site and a replay will be accessible for about one year.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – LMRI
On the day this news was published, LMRI gained 0.32%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
No peer stocks were flagged in the momentum scanner, suggesting the 1.15% move was company-specific rather than part of a broader sector pattern.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 20 | Executive appointment | Positive | -0.1% | Named a Chief Growth Officer to drive JVs, acquisitions, and development. |
| Mar 26 | Earnings and guidance | Positive | -29.8% | Reported Q4 and 2025 results and reiterated full-year 2026 guidance. |
| Feb 17 | Investor conferences | Positive | +6.0% | Announced CEO/CFO participation in multiple March investor conferences. |
| Jan 28 | Leadership recognition | Positive | -2.8% | Executive elected to RSNA board, highlighting quality and patient focus. |
| Jan 08 | Expansion update | Positive | +2.5% | Reported record de novo openings and a footprint of 185+ centers. |
Recent positive corporate and financial updates often saw mixed or negative price reactions, with only some growth/expansion headlines aligning with upside moves.
This announcement schedules the first quarter 2026 results call, following several growth- and visibility-related updates. In March 2026, Lumexa reported Q4 and full-year 2025 results and reiterated 2026 guidance, yet shares fell nearly 30%. Earlier, de novo expansion, leadership recognition, and investor conference participation were highlighted, with price reactions alternating between gains and modest declines. Together with the upcoming call date, this points to a company steadily communicating execution and outlook while the stock trades well below its 52-week high.
Market Pulse Summary
This announcement sets the timing for Lumexa’s first quarter 2026 earnings release and call, adding to a steady cadence of communications around growth, guidance, and investor outreach. With shares below the 200-day MA and well under the 52-week high, investors may focus on upcoming reported revenue, profitability, and leverage trends discussed in recent filings. Key watchpoints include any updates to 2026 guidance and execution on expansion and joint venture strategies.
AI-generated analysis. Not financial advice.
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.
The live audio webcast will be available in the Investor Relations section of the Company’s website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year.
About Lumexa Imaging
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
Media Contact
Melissa Weston
Melissa.Weston@LumexaImaging.com
IR Contact
Sue Dooley
Sue.Dooley@LumexaImaging.com
